Drug comparisons
Nateglinide vs Tolazamide
Nateglinide is a short-acting meglitinide that stimulates insulin secretion for postprandial control, while Tolazamide is a sulfonylurea with longer action. Both lower blood glucose by closing KATP channels on beta cells but differ in onset and duration. Selection depends on meal patterns and patient factors.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes inadequately controlled by metformin or lifestyle modifications may require comparison of nateglinide and tolazamide.
Bottom line
Nateglinide and Tolazamide are both effective oral antidiabetics that stimulate insulin secretion from pancreatic beta cells, but the optimal choice depends on individual patient factors such as meal timing and duration needs.
All medication comparisons